Document is current
Any future updates will be listed below
-
Authors
Yang, Lanting
Tang, Shangbin
Guo, Jingchuan
Gabriel, Nico
Fendrick, A. Mark
Patel, Nimish
Essien, Utibe R.
Magnani, Jared W.
Gellad, Walid F.
Hernandez, Inmaculada
-
Funding
Funding for this research was provided by:
PhRMA Foundation (Research Starter Award)
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK133465)
National Heart, Lung, and Blood Institute (R01HL15705, R01HL143010, K01HL142847)
- License Information
-
More Information
Article History
Received: 7 August 2025
Accepted: 27 October 2025
First Online: 27 November 2025
Declarations
:
: This study was conducted in accordance with the principles of the Declaration of Helsinki. The University of California San Diego Institutional Review Board (IRB) reviewed and determined it to be exempt under Exempt Category 4 of the U.S. federal regulations, as it involved secondary analysis of existing data recorded without identifiers.
: Not applicable.
: Nimish Patel reports financial support was provided by National Heart Lung and Blood Institute Division of Intramural Research. Dr. Magnani is funded by K24HL160527. Dr. Guo is funded by NIDDK R01DK133465 and PhRMA Foundation Research Starter Award. The funders had no role in design and conduct of the study, collection, management, analysis, and interpretation of the data, preparation, review, or approval of the manuscript, and decision to submit the manuscript for publication. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
